Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Year-over-year debt growth rate
3Y CAGR
+49.0%/yr
Quarterly compound
Percentile
P93
Near historical high
vs 3Y Ago
3.3x
Strong expansion
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 3.10% |
| Q3 2025 | -33.28% |
| Q2 2025 | 58.90% |
| Q1 2025 | 0.00% |
| Q4 2024 | -100.00% |
| Q3 2024 | -49.70% |
| Q2 2024 | -32.94% |
| Q1 2024 | -24.78% |
| Q4 2023 | 0.90% |
| Q3 2023 | 0.91% |
| Q2 2023 | 0.92% |
| Q1 2023 | 0.93% |
| Q4 2022 | 0.94% |
| Q3 2022 | -28.09% |
| Q2 2022 | -82.02% |
| Q1 2022 | 1456.60% |
| Q4 2021 | -77.79% |
| Q3 2021 | -8.44% |
| Q2 2021 | -7.67% |
| Q1 2021 | 0.00% |
| Q4 2020 | 0.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |